Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
Clinical trial NCT06422247 · COMPLETED
Trial details
- NCT number
- NCT06422247
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-05
- Primary completion
- 2025-02-05
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.